Practice
Featured experience
Bristol Myers Squibb $13 billion notes offering
The investment-grade offering comprised nine tranches
Cisco Systems $13.5 billion notes offering
The investment-grade offering comprises seven tranches of notes
Galderma Group CHF2.3 billion ($2.6 billion) IPO
We advised Galderma on its IPO
Novartis $3.7 billion notes offering
We advised Novartis on the investment-grade debt offering
Nutanix $862.5 million convertible senior notes offering
The 0.50% convertible senior notes are due 2029
VersaBank $75 million follow-on offering
The common shares are dual-listed on the Nasdaq Global Select Market and the Toronto Stock Exchange
Toronto-Dominion Bank $3.3 billion notes offering
The investment-grade debt offering consists of four tranches
Pampa Energía $360 million notes offering
The 7.875% notes are due 2034
Hertz $500 million senior notes offering and concurrent consent solicitations
We advised Hertz on the transactions
Shyft Group merger with Aebi Schmidt Group
We are advising Shyft Group on the transaction
Ormat Technologies $282 million secondary offering
The stock is listed on the NYSE and Tel Aviv Stock Exchange
Chewy $575 million secondary offering
The shares are listed on the New York Stock Exchange
AppLovin $3.55 billion debut senior notes offering
The investment-grade notes are due 2029, 2031, 2034 and 2054
Lockheed Martin $1 billion senior notes offering
The investment-grade notes are due 2031 and 2055